Swedish Pharmaceuticals & Biotech High Growth Potential Companies

Ascelia Pharma

Market Cap: SEK 294.1m

A biotech company, focuses on orphan oncology treatments in Sweden.

Elicera Therapeutics

Market Cap: SEK 214.5m

A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.

Corline Biomedical

Market Cap: SEK 266.9m

Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications.

Camurus

Market Cap: SEK 34.6b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic conditions in Europe, Australia, the United States, and internationally.

Bonesupport Holding

Market Cap: SEK 19.7b

An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

Devyser Diagnostics

Market Cap: SEK 1.6b

Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.

Xbrane Biopharma

Market Cap: SEK 299.2m

A biotechnology company, engages in the development, manufacture, and sale of biosimilars.

BioArctic

Market Cap: SEK 17.2b

Develops biological drugs for patients with disorders of the central nervous system in Sweden.

Newbury Pharmaceuticals

Market Cap: SEK 74.7m

Operates as hybrid pharmaceutical company in Sweden and the Scandinavian market.

Klaria Pharma Holding AB (publ.)

Market Cap: SEK 157.8m

Operates as a pharmaceutical company.

SenzaGen

Market Cap: SEK 165.8m

Provides non-animal tests for assessing a substance’s allergenicity.

Egetis Therapeutics

Market Cap: SEK 1.4b

A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.

BioInvent International

Market Cap: SEK 2.0b

A clinical-stage company, discovers, and develops novel immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally.

Active Biotech

Market Cap: SEK 104.8m

A biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden.

Hansa Biopharma

Market Cap: SEK 1.7b

A biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe.

Moberg Pharma

Market Cap: SEK 359.5m

A pharmaceutical company, develops and commercializes medical products primarily in Sweden.

Xspray Pharma

Market Cap: SEK 1.2b

A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.

Modus Therapeutics Holding

Market Cap: SEK 45.6m

A biotechnology company, develops a treatment for sepsis and septic shock in Sweden.

AddLife

Market Cap: SEK 21.3b

Provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries.

Magle Chemoswed Holding

Market Cap: SEK 562.1m

Operates as a contract development and manufacturing organization that serves pharmaceutical and medical device industry on a contract basis in Sweden.

BICO Group

Market Cap: SEK 2.6b

Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.

Swedencare

Market Cap: SEK 6.0b

Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.

Biotage

Market Cap: SEK 11.3b

Provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing.

AlzeCure Pharma

Market Cap: SEK 210.1m

A pharmaceutical company, develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system.

FluoGuide

Market Cap: SEK 543.4m

A clinical stage biotechnology company, focuses on developing drugs for surgical outcomes by making cancer fluorescent in Denmark.

Lipigon Pharmaceuticals

Market Cap: SEK 17.8m

Develops drugs for lipid related diseases in Sweden.

Vitrolife

Market Cap: SEK 20.4b

Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.

Cantargia

Market Cap: SEK 408.2m

A biotechnology company, develops antibody-based treatments for life threatening diseases.

SynAct Pharma

Market Cap: SEK 947.8m

A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.

BioGaia

Market Cap: SEK 10.1b

A healthcare company, provides probiotic products worldwide.

Guard Therapeutics International

Market Cap: SEK 265.2m

A pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden.